Last update 20 Feb 2025
Changchun Pan-Chinapharm Co. Ltd.

Changchun Pan-Chinapharm Co. Ltd.

Subsidiary Company|
1997|
Jilin Sheng, China
|
www.pan-chinapharm.com

Overview

Tags

Nervous System Diseases
Other Diseases
Eye Diseases
Small molecule drug
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Immune System Diseases1
Infectious Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Herbal medicine1
Top 5 TargetCount
TRPV1(Transient receptor potential cation channel subfamily V member 1)1

Related

2
Drugs associated with Changchun Pan-Chinapharm Co. Ltd.
Capsaicin
Target
TRPV1
Mechanism
TRPV1 agonists
Active Org.
Propella Therapeutics, Inc.Propella Therapeutics, Inc. [+5]
Originator Org.
NeurogesX Pharmaceuticals PLC
Active Indication
Diabetic peripheral neuropathic pain [+9]
Inactive Indication
Breast Cancer [+13]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date24 Jan 2003
FuFangXiongDan
Target-
Mechanism-
Active Org.
Changchun Pan-Chinapharm Co. Ltd.Changchun Pan-Chinapharm Co. Ltd.
Originator Org.
Changchun Pan-Chinapharm Co. Ltd.Changchun Pan-Chinapharm Co. Ltd.
Active Indication
Conjunctivitis, Bacterial [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 2000
100 Clinical Results associated with Changchun Pan-Chinapharm Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Changchun Pan-Chinapharm Co. Ltd.
Login to view more data
100 Deals associated with Changchun Pan-Chinapharm Co. Ltd.
Login to view more data
100 Translational Medicine associated with Changchun Pan-Chinapharm Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
1
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free